Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 2Terminated 1Suspended 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 7

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Genitourinary 7

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Tuberous Sclerosis 1Thyroid Neoplasms 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphangioleiomyomatosis 1Lipodystrophy, Familial Partial 1Kidney Neoplasms 1Histiocytosis, Non-Langerhans-Cell 1

Interventions

enzalutamide 94Magnetic Resonance Spectroscopy 85Specimen Handling 66Prednisone 64Androgen Antagonists 59Abiraterone Acetate 58apalutamide 56Radiosurgery 52darolutamide 48Radiotherapy 47Leuprolide 47abiraterone 45Docetaxel 42Pluvicto 32Biopsy 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Radiation 30relugolix 28Surveys and Questionnaires 28gallium 68 PSMA-11 26Standard of Care 26pembrolizumab 25Goserelin 25Triptorelin Pamoate 24Gonadotropin-Releasing Hormone 23bicalutamide 22Brachytherapy 21Carboplatin 20cabazitaxel 19X-Rays 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Genetic Testing × 1 year × Clear all
NCT06632977 2026-06-02

PREDICT

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting
474 enrolled
Genitourinary

Prostatic Neoplasms

NCT07377006 2026-02-18

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
108 enrolled
Genitourinary

Prostatic Neoplasms

NCT04254133 2026-01-30

GIFTS

Fred Hutchinson Cancer Center

Enrolling by invitation
1,360 enrolled
Genitourinary

Prostatic Neoplasms

NCT04763980 2025-12-31

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

University of California, San Francisco

Phase NA Recruiting
72 enrolled
Genitourinary

Prostatic Neoplasms

NCT04447703 2025-12-02

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Thomas Jefferson University

Phase NA Completed
346 enrolled
Genitourinary

Prostatic Neoplasms

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Terminated
799 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03694483 2025-08-22

Prostasomes as Diagnostic Tool for Prostate Cancer Detection

Hackensack Meridian Health

Suspended
600 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡